Formulation: A crystalline solid

Purity: ≥98%

Schedule: I

• 2-methyl Buccinazine

Formulation: A crystalline solid

Purity: ≥99% deuterated forms (d₁-d₇)

Schedule: I

• 2-methyl Buccinazine-d₇

Formulation: A crystalline solid

Purity: ≥98%

• 2,6-dimethyl Propionyl AP-237

Formulation: A crystalline solid

Purity: ≥98%

• Buccinazine
• 1-Butyryl-4-cinnamylpiperazine

Formulation: A crystalline solid

Purity: ≥98%

• p-methyl AP-237
• p-methyl Buccinazine
• para-methyl Buccinazine

Formulation: A crystalline solid

Purity: ≥98%

• 4'-hydroxy 2-methyl AP-237
• p-hydroxy 2-methyl AP-237

Formulation: A 1 mg/ml solution in methanol

• 2-methyl Buccinazine

Formulation: A solid

Purity: ≥98%

• 1-(3-Cinnamyl-3,8-diazabicyclo[3.2.1]octan-8-yl)propan-1-one
• 3-Cinnamyl-8-propionyldiazabicyclo[3.2.1]octane

Formulation: A 100 μg/ml solution in methanol

Purity: ≥99% deuterated forms (d₁-d₇)

• 2-methyl Buccinazine-d₇

Formulation: A solid

Purity: ≥98%

• DBO 17